Cargando…
Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores
Autores principales: | van den Hoogen, Lucas L, Palla, Giovanni, Bekker, Cornelis P J, Fritsch-Stork, Ruth D E, Radstake, Timothy R D J, van Roon, Joel A G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045704/ https://www.ncbi.nlm.nih.gov/pubmed/30018806 http://dx.doi.org/10.1136/rmdopen-2018-000693 |
Ejemplares similares
-
Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019) -
B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
por: van den Hoogen, Lucas L., et al.
Publicado: (2022) -
The current status of targeting BAFF/BLyS for autoimmune diseases
por: Ramanujam, Meera, et al.
Publicado: (2004) -
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
por: Collins, Christopher E, et al.
Publicado: (2006) -
High Expression Levels of BLyS/BAFF by Blood Dendritic Cells and Granulocytes Are Associated with B-cell dysregulation in SIV-Infected Rhesus Macaques
por: Poudrier, Johanne, et al.
Publicado: (2015)